A detailed history of Y Intercept (Hong Kong) LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 15,891 shares of LLY stock, worth $12 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
15,891
Holding current value
$12 Million
% of portfolio
0.89%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $12.3 Million - $15.3 Million
15,891 New
15,891 $14.1 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $1.21 Million - $1.42 Million
2,298 New
2,298 $1.34 Million
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $589,513 - $692,176
-2,115 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $496,369 - $616,860
2,115 New
2,115 $606,000
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $851,282 - $1.06 Million
-3,786 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $838,977 - $1.03 Million
3,786 New
3,786 $875,000
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $1.96 Million - $2.54 Million
-10,869 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $1.79 Million - $2.31 Million
10,869 New
10,869 $2.02 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $720B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.